SPDR S&P Biotech ETF (XBI) Stock Price, News, Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US ETFDetailed Quotes

XBI SPDR S&P Biotech ETF

Watchlist

92.310
-0.560-0.60%

Close Jan 8 16:00 ET

93.150High91.580Low

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
Kevin Travers16:12 ET
Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators
Benzinga14:32 ET
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development
Benzinga14:09 ET
Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
Benzinga14:07 ET
Assessing AbbVie: Insights From 17 Financial Analysts
Benzinga14:00 ET
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Benzinga12:54 ET

Comments

Kim10

3 hours ago

$SPDR S&P Biotech ETF (XBI.US)$ big bearish flow coming in looking like a hedge. Potential put play, small size.

topcing

Nov 4, 2024 21:29

$SPDR S&P Biotech ETF (XBI.US)$ yea

股勇者

Oct 25, 2024 10:17

$SPDR S&P Biotech ETF (XBI.US)$ 100 month end? ok?

Bellaah

Sep 11, 2024 11:10

$SPDR S&P Biotech ETF (XBI.US)$ 95

Moomoo Learn

Sep 6, 2024 03:05

Columns Navigating the wave of lower interest rates

Given the strong market expectations for a Federal Reserve rate cut, as indicated by the CME data with a 57% chance for a 25-basis-point reduction and a 43% chance for a 50-basis-point cut in September, investors are poised to reconsider their strategies.
With the Fed's September meeting likely to deliver a rate decrease, the question arises: how should investors allocate assets during an interest rate cut cycle? Let's delve into the tactics and consid...

CPI hits 3-year low: How will it sway the Fed rate decision?